Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status

ConclusionsIn our study, biomarkers have not been associated with an increased risk of VTE in CRC patients. A high incidence of VTE in BRAF-mutated patients has been observed and should be explored in further studies.

http://link.springer.com/10.1007/s12094-020-02339-1

Source: Clinical and Translational Oncology - April 7, 2020 Category: Cancer & Oncology Source Type: research